TNF and COVID-19: Therefore, in this paper, we analyzed soluble inflammatory mediators from the TNF superfamily to assess if they can directly influence clinical decision making when used as predictors for the clinical outcomes of COVID-19 patients in combination with routine laboratory tests and statistical modeling.